Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

164 results about "Conditioned medium" patented technology

Conditioned medium is spent media harvested from cultured cells. It contains metabolites, growth factors, and extracellular matrix proteins secreted into the medium by the cultured cells.

Methods for culturing mesenchymal stem cells, compositions and implementations thereof

There is provided herein methods generating a population of primed mesenchymal stem cell-derived exosomes. A method in accordance with the disclosure may comprise expanding a population of mesenchymal stem cells (MSCs) in culture, administering one or more priming agents in the culture to prime the population of MSCs and obtain a population of primed MSCs: growing the population of die primed MCSs in culture to produce a primed-MSC-derived conditioned medium; collecting the primed MSC-conditioned medium; and purifying a population of exosomes from the primed MSC-conditioned medium. The one or more priming p agents may comprise a conditioned media derived from a population of stem cells different from the population of MSCs, a Nrf2 activator, or a combination thereof. There is also provided herein methods of treating tissues such as cornea and liver using the population of exosomes from the primed MSC-conditioned medium.
Owner:PANDORUM TECH PTE LTD

Method for culturing primary cells (PDC) from glioma patient

The invention relates to the related technical field of primary cell (PDC) culture, in particular to a method for culturing primary cells (PDC) from glioma patients, which comprises a series of steps of Swis3T3-J2 cell culture, conditioned medium preparation, brain tumor tissue pretreatment, primary tumor cell digestion and culture and the like. Primary human tumor cells are cultured by a conditioned culture medium generated by fibroblasts irradiated by X-rays (X) and a cobalt-60 radioactive source (60Co), and culture conditions of key features of parent tumors and a modeling process can be most effectively reserved by screening and optimizing the culture conditions. And whether the PDC retains the key characteristics of the parent tumor or not is inspected on the aspects of the cell molecular level, the cell phenotype, the animal intracranial tumor model and the like.
Owner:NANJING UNIV

Preparation method and application of conditioned culture solution for improving development rate of bovine in-vitro embryos

The invention discloses a preparation method and application of a conditioned culture solution for improving the development rate of bovine in-vitro embryos. The preparation method comprises the following steps: culturing immortalized bovine endometrial epithelial cells by using a DMEM / F12 cell culture solution containing 10% FBS, collecting the cell culture solution in the culture process, and filtering to obtain an immortalized bovine endometrial epithelial cell conditional culture solution, namely the conditional culture solution capable of improving the development rate of the bovine in-vitro embryos. The prepared conditioned culture solution can simulate a liquid environment of an in-vivo environment, is used for culturing in-vitro embryos such as parthenogenetic activated embryos and in-vitro fertilized embryos, improves the cleavage rate and blastocyst rate of the in-vitro embryos and improves the development rate of the in-vitro embryos of cattle.
Owner:INNER MONGOLIA UNIVERSITY

Stem cell freeze-dried powder for promoting skin healing and preparation method thereof

The invention discloses stem cell freeze-dried powder for promoting skin healing and a preparation method of the stem cell freeze-dried powder. The freeze-dried powder comprises an effective component, a freeze-drying protective agent group and a polymer protective agent group, the effective component is umbilical cord mesenchymal stem cell conditioned medium freeze-dried supernatant, the protective agent group is selected from one or more of cane sugar, trehalose, lactose and mannitol, and the polymer protective agent group is selected from one or more of polyvinylpyrrolidone (PVP) and glucan. The preparation method comprises the following steps: collection of a conditioned culture medium, preparation of a freeze-drying protective agent solution, mixing treatment, low-temperature pre-freezing and freeze-drying, collection and packaging of freeze-dried powder and the like. The method can effectively retain stem cell-derived active factors and enhance the stability and redissolvability of the freeze-dried powder, and is suitable for skin wound repair, regenerative medicine and other scenes.
Owner:JIAXING UNIV

Mesenchymal progenitor cells for enhancing partial reprogramming of target cells

Provided herein are methods and related compositions for enhancing or enhanced partial reprogramming of target cells in a subject in need thereof (e.g., a human subject suffering from or at risk of a disease), the method comprising administering a plurality of mesenchymal lineage progenitor or stem cells (MLPSCs), exosomes derived therefrom, or conditioned culture media derived therefrom to a subject that expresses or will express one or more reprogramming factors in a population of target cells, whereby a plurality of the target cells in the subject become partially reprogrammed, but not fully reprogrammed.
Owner:MESOBLAST INTERNATIONAL SARL

Human hepatocyte culture medium and conditioned medium of in vitro cultured human hepatocytes and uses thereof

HH culture media and methods are provided to allow for recovery from injury or stress associated with cell isolation procedures and freeze / thaw cycle(s) by the use of a DMSO-supplemented medium, i.e., Phase 1 (recovery-phase). Moreover, HH culture media and methods are provided to allow for support of hepatic functionality of cultured HH at a comparable level to that of the human liver by the use of a DMSO, DMSO2, or TMSO-supplemented medium, i.e., Phase 2 (maintenance-application phase). These HH are suitable for the in vitro study of liver biology, diseases drug metabolism and pharmacokinetics. Furthermore, the culture supernatant of HH during Phase 2, namely, conditioned culture medium of human hepatocytes (CMHH), is provided, which facilitates iHeps maturation and supports the cell fate maintenance of hepatocytes. Methods of preparing CMHH are also provided, including culturing humanized liver chimeric animal derived-human hepatocytes and / or primary human hepatocytes in a medium to be collected.
Owner:UNIV OF SOUTHERN CALIFORNIA +1

Personalized progenitor cells

Tissue specific progenitor cells generated from pluripotent sources representing endoderm, ectoderm and mesoderm lineages. Progenitor generation can be accomplished by contacting pluripotent stem cells with tissue-specific exosomes, microRNAs, proteins and peptides obtained from stressing said tissue ex vivo. Ex vivo generated tissue organoids which are utilized as sources of "differentiation factors" for the creation of personalized progenitor cells. For generation of pulmonary progenitor cells, decellularized cadaveric lung is populated with allogeneic stem cells to form pulmonary structures, said structures are exposed to various cellular stressors and conditioned media to differentiate pluripotent stem cells into progenitor cells. Extracellular matrix can be obtained from decellularized structures seeded with regenerative cells and used to create organoids that are subjected to stress in order to generate differentiating factors.
Owner:IMMORTA BIO INC

Actin reorganization inhibitor, phagocytosis inhibitor, stain formation inhibitor containing the inhibitor, and external skin preparation containing the inhibitor

To provide actin reorganization inhibitors and phagocytosis inhibitors, which inhibit the actin reorganization and induction of phagocytosis in epidermal keratinocytes by contacting the epidermal keratinocytes with a fibroblast conditioned medium; to provide stain formation inhibitors containing the inhibitor; and to provide external skin preparations containing the inhibitor.SOLUTION: Provided is an inhibitor that inhibits the actin reorganization and induction of phagocytosis in epidermal keratinocytes by contacting the epidermal keratinocytes with a fibroblast conditioned medium, and contains a specific plant extract or a specific compound as an active ingredient. Also provided are a spot formation inhibitor composed of the inhibitor, and a skin external preparation containing the inhibitor.SELECTED DRAWING: None
Owner:PICASO COSMETIC LAB

Compositions containing the secretome of dsrna-primed cells and methods of use thereof for tissue regeneration / repair

Provided herein are cell-free compositions containing the secretome / exosomes of dsRNA primed cells ("herein dsRNA-primed secretome / exosome). The dsRNA-primed secretome is obtained from conditioned media following cell culture (for an effective amount of time) of cells treated with dsRNA, either by transfecting the cells with dsRNA or incubating the cells with dsRNA. The dsRNA-primed secretome / / exosome can be administered to a subject in need thereof, by administering an effective amount of the dsRNA-primed secretome / exosomes to a subject in need thereof. Exemplary subjects / sites of treatment include subjects include, but are not limited to in need of wound healing such as skin wound healing, burn sites, subjects in need of bone repair such as osteochondral bone repair, bone fracture sites, corneal wound sites. Other subjects include osteoporotic subjects and subjects with intervertebral disc degeneration.
Owner:KING ABDULLAH UNIV OF SCI & TECH

Aerosol-type cosmetic pack

The invention provides an aerosol-type face pack cosmetic that, when dispensed, forms a flexible, easy-to-use, and low-irritation resin foam that easily adheres to the face, such as around the eyes and nose. It also allows the fermented liquid contained in the resin foam to easily seep out, making it easy to apply the fermented liquid to the face and less likely to cause tightness. [Solution] An aerosol pack cosmetic comprising a beauty serum and dimethyl ether, wherein the beauty serum comprises at least one fermentation solution selected from Saccharomyces / Anzange ferment filtrate, Saccharomyces / Human (fibroblast / mononuclear cell) induced pluripotent cell culture conditioned medium ferment filtrate, Galactomyces / Eryngium multiflorum callus culture ferment filtrate, and a resin.
Owner:BEAUTE DE LABO CO LTD +2

An in vitro screening model, screening method, and reagent kit for a candidate drug for the treatment of metabolic dysfunction-related fatty liver disease.

PendingCN123063493AMicrobiological testing/measurementArtificial cell constructsHepatic stellate cell activationMouse Dendritic Cell
This invention relates to an in vitro screening model, screening method, and kit for candidate drugs for the treatment of fatty liver disease (MAFLD). The in vitro screening method for MAFLD therapeutic candidates utilizes a non-contact co-culture system or conditioned medium system of dendritic cells and hepatic stellate cells, with hepatic stellate cell activation indicators as the functional endpoint for screening. The invention also includes an in vitro kit for detecting CD11c / Gal-3 colocalization signals in liver tissue and assisting in the assessment of MAFLD-related liver tissue pathology; and an siRNA composition for in vitro downregulating Lgals3 expression in mouse DC2.4 dendritic cells. This invention provides a new technical solution for in vitro drug screening and auxiliary assessment of liver tissue pathology in MAFLD.
Owner:SHANDONG UNIV

Construction method of gastric cancer organoid culture system

The invention relates to the technical field of biology, and discloses a construction method of a gastric cancer organoid culture system, which comprises the following steps: preparation of a conditioned medium: culturing L-WRN cells and collecting the conditioned medium; preparing a gastric cancer organoid culture medium, and mixing the conditioned culture medium, the basic culture medium, a plurality of growth factors and additives; and extraction and culture of organoid: separating cells from gastric cancer tissues, mixing the cells with matrigel, and culturing by using the prepared culture medium. According to the method, the repeatability and the stability of the organoid model are improved, the response consistency of the organoid in drug screening is improved, and the reliability of the model in disease mechanism research and personalized medical application is guaranteed.
Owner:CHANGZHI PEOPLES HOSPITAL (CHANGZHI OCCUPATIONAL DISEASE PREVENTION & CONTROL HOSPITAL) +2

Novel technical method for constructing ovarian cancer organoid

The invention relates to the technical field of biological medicine, and particularly discloses a culture medium formula for constructing ovarian cancer organoid and a culture method. The culture medium comprises the following components: L-glutamine 100x (L-Glutamine), L-glutamine 100x (L-Glutamine), L-glutamine 100x (L-Glutamine 4-hydroxyethylpiperazine ethanesulfonic acid (1M (hepes)); b-27 is free of a serum additive (B27); the preparation method comprises the following steps of: extracting the raw materials, namely nicotinamide; the preparation method comprises the following steps: adding N, N-acetylcysteine amide (N-Acetylcysteine); a forskolin element (Forskolin); and estradiol (beta-Estradiol), which is used for preparing the pharmaceutical composition. A TGF-[beta] inhibitor (A83-01); a p38 MAPK inhibitor (SB202190), and a p38 MAPK inhibitor, a p160ROCK small molecule inhibitor (Y27632); hepatocyte growth factor (HGF); the invention relates to a recombinant human Hergulin beta-1 protein product (Hergulin beta-1) and a preparation method of the recombinant human Hergulin beta-1 protein product. An epidermal growth factor (EGF); a fibroblast growth factor (FGF10); the invention relates to a method for preparing hydrocortisone. The method comprises the following steps: preparing hydrocortisone; and a primary cell antibiotic (Primocin). The culture solution and the culture method have the advantages that ovarian high-grade serous cancer cells can be effectively cultured and induced to develop into organoid. Noggin is not needed in the scheme, and the method is different from a traditional organoid culture method and is low in cost and simple in manufacturing process. Meanwhile, preparation of a conditioned culture medium is not needed, time can be remarkably saved, the situation that the conditioned culture medium is unstable due to too long time is avoided, and the success rate is high and is about 50%.
Owner:FIRST AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIV +1

Application of miR-206-3p in regulation and control of skeletal muscle atrophy

The invention belongs to the technical field of biological medicines, and particularly relates to application of miR-206-3p in regulation and control of skeletal muscle atrophy, and the change condition of the miR-206-3p level is measured by constructing an in-vitro cancer cachexia myotubular atrophy model; it is verified that in-vitro addition of miR-206-3p mimics relieves in-vitro myotube atrophy induced by a cancer conditioned culture medium, inhibits expression of a myotube marker gene and inhibits proteolysis and metabolism pathways and cell apoptosis of myotubes, so that myotube atrophy induced by cancer cachexia is inhibited. The invention opens up a new thought for the research of cachexia pathogenesis, and also provides a potential new target for the research and development of cachexia treatment and / or cachexia prevention drugs.
Owner:CHINA AGRI UNIV

Oral drug delivery system with double-emulsion structure and application of oral drug delivery system in preparation of drugs for treating premature ovarian insufficiency

The invention discloses an oral drug delivery system with a double-emulsion structure and application of the oral drug delivery system in preparation of drugs for treating premature ovarian insufficiency, and belongs to the technical field of biological medicines. The oral drug delivery system comprises droplet particles formed by wrapping an MSCs conditioned culture medium with an oil-phase solvent, and exosomes uniformly distributed on the outer surfaces of the droplet particles, so that a double-emulsion structure is formed. Water-soluble MSC-CM is wrapped by a water-in-oil-in-water method to form a double-emulsion structure, so that water-soluble protein enters a human body to be absorbed in an oral manner. The MSC-CM composite has good structural stability and viscoelasticity, the particle size range is about 10-50 microns, contact with intestinal epithelial cells can be increased, meanwhile, the skeleton of the intestinal epithelial cells can be changed, expression of tight junction protein of the intestinal epithelial cells can be lowered, tight junction barriers of the intestinal epithelial cells can be opened, and therefore the bioavailability of MSC-CM is improved, and the MSC-CM composite has a good application prospect. The effect of treating the POI is achieved.
Owner:SOUTHERN MEDICAL UNIVERSITY

Method for constructing human body end-stage atherosclerotic plaque model through additive manufacturing

The invention relates to a method for constructing a last-stage atherosclerotic plaque through additive manufacturing, and belongs to the technical field of tissue engineering. According to the method, firstly, cells are treated, then bio-ink for a fiber cap, bio-ink for a lipid nucleus and bio-ink for a suspension pool are prepared respectively, and then construction of the last-stage atherosclerotic plaque is completed through curing treatment. After a conditional culture solution and a stimulating factor are added, long-term in-vitro culture can be realized, and a real focus microenvironment can be simulated. The fibrous cap-lipid nucleus AS plaque constructed by the invention can maintain the stability and physiological function of the structure for a long time, and can accurately simulate hyperplasia, hypoxia, fat enrichment and inflammatory response of the AS plaque in the last stage.
Owner:BEIJING INST OF TECH

Feed-layer-free and serum-free bovine embryonic stem cell culture medium, culture system and culture method

The invention belongs to the technical field of cell biology, and particularly relates to a feeder-layer-free and serum-free bovine embryonic stem cell culture medium, a culture system and a culture method. The bovine embryonic stem cell culture medium comprises a conditioned culture medium and additives, the additives are IWR-1 and activin A, and the concentrations of the IWR-1 and the activin A in the conditioned culture medium are 2.5-5 [mu] M and 20-25 ng / mL respectively; the culture system comprises a bovine embryonic stem cell culture medium, gelatin with the mass concentration of 0.1-0.2% and a subculture medium, and the gelatin with the mass concentration of 0.1-0.2% is used for providing an attachment matrix for bovine embryonic stem cells; the subculture medium is prepared by adding Y27632 into a bovine embryonic stem cell culture medium. The cost of the extracellular matrix is reduced, and the feeder-layer-free bovine embryonic stem cell has high single cell passage efficiency and is convenient for gene editing operation.
Owner:NORTHWEST A & F UNIV

Application of dental pulp stem cell exosome in preparation of medicine for treating and preventing osteoarthritis

The invention relates to the technical field of biological medicine, and provides application of a dental pulp stem cell exosome in preparation of a medicine for treating and preventing osteoarthritis, a preparation method of the dental pulp stem cell exosome comprises the following steps: S1, obtaining dental pulp tissue from a dental pulp cavity of an in-vitro tooth; s2, pretreating dental pulp tissues, adding digestive juice, digesting, centrifuging, discarding supernatant, adding a complete culture medium containing antibiotics into precipitates, mixing, filtering and centrifuging to obtain dental pulp stem cells; and S3, culturing the dental pulp stem cells by using a complete culture medium, when the confluence degree of the dental pulp stem cells reaches 60-80%, replacing the serum-free culture medium for continuous culture, collecting the dental pulp stem cell conditioned culture medium, and performing differential centrifugation to obtain the dental pulp stem cell exosome. According to the technical scheme, the regulating effect of the dental pulp stem cell exosome on endoplasmic reticulum stress and the mechanism of the dental pulp stem cell exosome for improving cartilage cell degeneration are explored.
Owner:HEBEI MEDICAL UNIVERSITY

Application of human dental pulp stem cells in enhancing neurogenesis in brain region and treating neurodegenerative diseases

The invention discloses application of human dental pulp stem cells in enhancing neurogenesis in a brain region and treating neurodegenerative diseases, including stem cells for enhancing neurogenesis of adult hippocampus, and the human dental pulp stem cells have the following functional characteristics: flow cytometry detection shows that the Netin positive rate is not lower than 90%, and the beta-tubulin III positive rate is not lower than 85%; in a conditioned culture medium after in-vitro culture for 24 hours, the secretion amount of BDNF reaches more than 500pg / mL / 106 cells, and the secretion amount of GDNF reaches more than 200pg / mL / 106 cells; the alizarin red dyeing positive area accounts for not less than 60% after osteogenesis induction, and the oil red O dyeing positive area accounts for not less than 50% after adipogenesis induction; according to the quantitative standard that the number of dentate gyrus DCX + newborn neurons of the adult hippocampus is increased by more than 50% compared with that before treatment, the dual-mechanism targeted therapy 1 specifically activates hippocampus neural stem cells and promotes newborn neurons to differentiate by highly expressing neural markers and secreting neurotrophic factors, so that the neurogenesis of the adult hippocampus is enhanced, and the neurogenesis of the adult hippocampus is enhanced. Meanwhile, A beta deposition and p-Tau phosphorylation are reduced.
Owner:KEFUYUAN REGENERATIVE MEDICINE (HUBEI) CO LTD

Lyophilized compositions containing umbilical cord lining stem cells conditioned medium

Factor rich compositions produced from umbilical cord (UC) mesenchymal stem cells (MSCs) are described. Secretory UC MSCs in serum free culture conditions produce a factor rich conditioned medium which may be concentrated and filtered to obtain clinical grade products.
Owner:RESTEM LLC

Immortalized chicken embryonic epithelial-like cells, methods of making and using the same

The application discloses immortalized chicken embryo epithelioid cells and a preparation method and application thereof, and the preparation method of the immortalized chicken embryo epithelioid cells comprises the following steps: extracting primary chicken embryo epithelial cells from a chicken embryo; and culturing the primary chicken embryo epithelioid cells in a conditional medium containing chicken Noggin protein for subculture, so as to obtain the immortalized chicken embryo epithelioid cells. The immortalized chicken embryo epithelioid cells prepared by the preparation method can be stably subcultured for a long time, can maintain stable proliferation ability after multiple subcultures, reduces individual differences, and improves the reliability and repeatability of experimental results. In addition, the preparation method does not introduce exogenous genes or change the genotype of the cells, ensures the stability at the gene level, and avoids the interference of the exogenous genes on the stability of the cell phenotype.
Owner:HAINAN UNIVERSITY SANYA NANFAN RESEARCH INSTITUTE

Application of targeted Schwann cell lactic acid transport in preparation of medicine for treating gastric cancer and research on treatment method

According to the invention, case samples are analyzed through immunofluorescence and immunohistochemistry, and the clinical correlation of co-localization of lactic acid and Schwann cells and lactic dehydrogenase and subtypes thereof in gastric cancer samples is determined clinically; the invention finds that the Schwann cell conditioned medium can promote gastric cancer lactylation, proliferation and migration by secreting lactic acid; shRNA is adopted to inhibit lactic acid transport of Schwann cells, so that gastric cancer lactylation, proliferation and migration can be inhibited; the invention discovers that the Schwann cell conditioned medium promotes the expression of gastric cancer cell lactic acid transporters MCT1 and MCT4; through RNA sequencing and western blot, it is found that the Schwann cell conditioned medium promotes gastric cancer lactylation and finally promotes GluT1 expression. The invention researches the influence of Schwann cells on the growth of gastric cancer cells, and finds that lactic acid secreted by the Schwann cells can obviously promote the lactic acid acidification of the gastric cancer H3K9 site, and further promotes the proliferation and migration of the gastric cancer cells by increasing the expression of gastric cancer GluT1, which may indicate the key mechanism of the relationship between the cancer cells and tricarboxylic acid cycle.
Owner:林琳

Formula and preparation method of mesenchymal stem cell conditioned medium freeze-dried ball for facial wrinkle resistance and compactness

The invention discloses a formula and a preparation method of a mesenchymal stem cell conditioned culture medium freeze-dried ball for facial wrinkle resistance and firming, the prepared umbilical cord mesenchymal stem cell conditioned culture medium freeze-dried ball can effectively remove DPPH free radicals, has the wrinkle resistance and firming effects, can effectively improve the skin elasticity of a subject in a human body experiment, and can be used for preparing the umbilical cord mesenchymal stem cell conditioned culture medium freeze-dried ball for facial wrinkle resistance and firming. And wrinkles are reduced.
Owner:XINJIANG WESTERN SAIAO BIOTECHNOLOGY CO LTD

Ph-reversible leuco-BODIPY probe for in situ visualization of extracellular vesicles and their secretion from living cells

ActiveUS12578273B2Methine/polymethine dyesAzo dyesIntracellular vesicleExtracellular vesicle
The subject invention pertains to compositions of a probe comprising two pH-reversible forms, including the boron dipyrromethene (BODIPY) fluorescent form and the non-fluorescent leuco-BODIPY form, for use in confocal imaging methods of intracellular vesicles as well as extracellular vesicles that are present in conditioned culture medium and / or secreted by living cells, without inducing severe cytotoxicity.
Owner:THE CHINESE UNIVERSITY OF HONG KONG

Conditioned medium from cells cultured under hypoxic conditions and uses thereof

Compositions that include extracellular matrix material and / or conditioned medium obtained from cells cultured under hypoxic conditions in a suitable growth medium and methods for producing the compositions. The compositions may also include botanicals, peptides, seed extracts, marine extracts and / or bacterial ferments. The compositions may be used to repair and regeneration of skin tissue.
Owner:ALLERGAN SALES LLC

Individualized progenitor cells

PendingCN122514591AGerm layerLung structure
Tissue-specific progenitor cells representing the endoderm, ectoderm, and mesoderm lineages are generated from pluripotent sources. Progenitor cell generation is accomplished by contacting pluripotent stem cells with tissue-specific exosomes, microRNAs, proteins, and peptides, obtained by stressing the tissue under in vitro conditions. In vitro-generated tissue organoids are used as a source of "differentiation factors" for generating individualized progenitor cells. For example, to generate lung progenitor cells, allogeneic stem cells are implanted into decellularized cadaveric lung tissue to form lung structures, which are then exposed to various cellular stressors and conditioned media to differentiate the pluripotent stem cells into progenitor cells. Extracellular matrix can be obtained from decellularized structures seeded with regenerating cells and used to generate organoids, which are then subjected to stress to produce differentiation factors.
Owner:IMOTA BIOTECHNOLOGY CO LTD

Composition for delaying cell senescence and maintaining tissue homeostasis as well as preparation method and application of composition

The invention belongs to the technical field of tissue engineering and aging resistance, and particularly relates to a composition for delaying cell aging and maintaining tissue homeostasis as well as a preparation method and application of the composition. Specifically, research finds that adipose tissues, skin tissues and the like are placed in a serum-free basal culture medium, adherent culture is performed, the obtained supernate is collected, and the obtained serum-free conditioned culture medium preparation can effectively inhibit aging of cells (such as ADSCs or HDFs) and maintain the functional steady state of the cells in in-vitro culture. Meanwhile, the culture medium product provided by the invention is also proved to be capable of inhibiting an IL-6 / STAT3 signal channel, and the channel is revealed to be a core mechanism of the anti-aging effect of the culture medium product, so that mechanism support is provided for the application of the culture medium product to cell aging resistance, and the culture medium product has good practical application value.
Owner:SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG PROVINCIAL HOSPITAL)

Stem cell conditioned medium filtering device

The utility model discloses a stem cell conditioned medium filter device which comprises a filter device shell, a filter tank is arranged in the filter device shell, a square sleeve is arranged on the lower side in the filter tank, a coarse-mesh filter screen is fixedly arranged in the square sleeve, and a filter screen is arranged in the coarse-mesh filter screen. A plurality of fine-hole filter screens fixed in the square sleeve are fixedly arranged below the coarse-hole filter screen; a sealing plate fixed in the square sleeve is arranged above the coarse-mesh filter screen, and a first stepping motor is fixedly mounted in the sealing plate. According to the utility model, the situation that the filter holes in the filter screen are blocked by cell debris, dead cells or metabolic wastes in the stem cell conditioned culture medium and even penetrate through the filter holes due to relatively intense impact generated between the filter screen and the stem cell conditioned culture medium when the filter screen is used for filtering the stem cell conditioned culture medium is prevented; through the technical scheme, the filtering effect of the equipment is improved.
Owner:ZHEJIANG JINSHIDAI BIOTECH